Literature DB >> 28982667

Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans.

Xiaobo Lin1, Susan B Racette1, Lina Ma1, Michael Wallendorf1, Victor G Dávila-Román1, Richard E Ostlund2.   

Abstract

OBJECTIVE: Epidemiological studies strongly suggest that lipid factors independent of low-density lipoprotein cholesterol contribute significantly to cardiovascular disease risk. Because circulating lipoproteins comprise only a small fraction of total body cholesterol, the mobilization and excretion of cholesterol from plasma and tissue pools may be an important determinant of cardiovascular disease risk. Our hypothesis is that fecal excretion of endogenous cholesterol is protective against atherosclerosis. APPROACH AND
RESULTS: Cholesterol metabolism and carotid intima-media thickness were quantitated in 86 nondiabetic adults. Plasma cholesterol was labeled by intravenous infusion of cholesterol-d7 solubilized in a lipid emulsion and dietary cholesterol by cholesterol-d5 and the nonabsorbable stool marker sitostanol-d4. Plasma and stool samples were collected while subjects consumed a cholesterol- and phytosterol-controlled metabolic kitchen diet and were analyzed by mass spectrometry. Carotid intima-media thickness was negatively correlated with fecal excretion of endogenous cholesterol (r=-0.426; P<0.0001), total cholesterol (r=-0.472; P≤0.0001), and daily percent excretion of cholesterol from the rapidly mixing cholesterol pool (r=-0.343; P=0.0012) and was positively correlated with percent cholesterol absorption (r=+0.279; P=0.0092). In a linear regression model controlling for age, sex, systolic blood pressure, hemoglobin A1c, low-density lipoprotein, high-density lipoprotein cholesterol, and statin drug use, fecal excretion of endogenous cholesterol remained significant (P=0.0008).
CONCLUSIONS: Excretion of endogenous cholesterol is strongly, independently, and negatively associated with carotid intima-media thickness. The reverse cholesterol transport pathway comprising the intestine and the rapidly mixing plasma, and tissue cholesterol pool could be an unrecognized determinant of cardiovascular disease risk not reflected in circulating lipoproteins. Further work is needed to relate measures of reverse cholesterol transport to atherosclerotic disease. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01603758.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; carotid intima-media thickness; cholesterol; clinical trial; mass spectrometry

Mesh:

Substances:

Year:  2017        PMID: 28982667      PMCID: PMC5699927          DOI: 10.1161/ATVBAHA.117.310081

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  35 in total

1.  The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease.

Authors:  Guenther Silbernagel; Guenter Fauler; Wilfried Renner; Eva M Landl; Michael M Hoffmann; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März
Journal:  J Lipid Res       Date:  2008-09-03       Impact factor: 5.922

2.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; T A Manolio; G L Burke; S K Wolfson
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

3.  Ezetimibe Increases Endogenous Cholesterol Excretion in Humans.

Authors:  Xiaobo Lin; Susan B Racette; Lina Ma; Michael Wallendorf; Richard E Ostlund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

4.  Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.

Authors:  I J Goldberg; S Holleran; R Ramakrishnan; M Adams; R H Palmer; R B Dell; D S Goodman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 5.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

6.  Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.

Authors:  Michael H Davidson; Jason Voogt; Jayraz Luchoomun; Julie Decaris; Salena Killion; Drina Boban; Alexander Glass; Hussein Mohammad; Yun Lu; Deona Villegas; Richard Neese; Marc Hellerstein; David Neff; Thomas Musliner; Joanne E Tomassini; Scott Turner
Journal:  Atherosclerosis       Date:  2013-08-13       Impact factor: 5.162

7.  Moderately elevated plant sterol levels are associated with reduced cardiovascular risk--the LASA study.

Authors:  Klaus Fassbender; Dieter Lütjohann; Miranda G Dik; Marijke Bremmer; Jochem König; Silke Walter; Yang Liu; Maryse Letièmbre; Klaus von Bergmann; Cees Jonker
Journal:  Atherosclerosis       Date:  2006-11-29       Impact factor: 5.162

8.  Improved estimation of body masses and turnover of cholesterol by computerized input--output analysis.

Authors:  P Samuel; S Lieberman
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

9.  Three-pool model of the long-term turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

10.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.

Authors:  Daniel J Rader; Eric T Alexander; Ginny L Weibel; Jeffrey Billheimer; George H Rothblat
Journal:  J Lipid Res       Date:  2008-12-08       Impact factor: 5.922

View more
  7 in total

Review 1.  High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.

Authors:  Yi He; Vishal Kothari; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

2.  Updates on Approaches for Studying Atherosclerosis.

Authors:  Congqing Wu; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

3.  Inflammatory Factors Driving Atherosclerotic Plaque Progression New Insights.

Authors:  Boce Song; Yulong Bie; Haoxin Feng; Beili Xie; Mingwang Liu; Fuhai Zhao
Journal:  J Transl Int Med       Date:  2022-04-02

4.  The coronary artery calcium score is linked to plasma cholesterol synthesis and absorption markers: Brazilian Longitudinal Study of Adult Health.

Authors:  Valéria Sutti Nunes; Isabela M Bensenor; Paulo A Lotufo; Marisa Passarelli; Edna Regina Nakandakare; Eder Carlos Rocha Quintão
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 5.  A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels.

Authors:  Takanari Nakano; Ikuo Inoue; Takayuki Murakoshi
Journal:  Nutrients       Date:  2019-02-01       Impact factor: 5.717

6.  Ultrasound Core Laboratory for the Household Air Pollution Intervention Network Trial: Standardized Training and Image Management for Field Studies Using Portable Ultrasound in Fetal, Lung, and Vascular Evaluations.

Authors:  Víctor G Dávila-Román; Ashley K Toenjes; Rachel M Meyers; Pattie M Lenzen; Suzanne M Simkovich; Phabiola Herrera; Elizabeth Fung; Aris T Papageorghiou; Rachel Craik; John P McCracken; Lisa M Thompson; Kalpana Balakrishnan; Ghislaine Rosa; Jennifer Peel; Thomas F Clasen; Shakir Hossen; William Checkley; Lisa de Las Fuentes
Journal:  Ultrasound Med Biol       Date:  2021-04-01       Impact factor: 2.998

7.  Plasma lathosterol measures rates of cholesterol synthesis and efficiency of dietary phytosterols in reducing the plasma cholesterol concentration.

Authors:  Valéria Sutti Nunes; Angela de Oliveira Godoy Ilha; Guilherme da Silva Ferreira; Renata de Paula Assis Bombo; Milessa Silva Afonso; Maria Silvia Ferrari Lavrador; Roberta Marcondes Machado; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Ana Maria Lottenberg
Journal:  Clinics (Sao Paulo)       Date:  2022-04-06       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.